Skip to content

Welcome to Discover Pharma! Today is : October 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

decompensated cirrhosis

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    Resolution Therapeutics partners with Blood Centers of America for RTX001 programme

    Resolution Therapeutics has partnered with Blood Centers of America to [...]

    September 16, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Resolution Therapeutics completes Phase 1/2 RTX001 liver disease trial dosing

    Resolution Therapeutics has treated the final patient in its Phase [...]

    September 16, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    First patient dosed in Resolution Therapeutics’ Emerald study of RTX001 for cirrhosis

    Resolution Therapeutics, a clinical-stage biopharmaceutical company developing regenerative macrophage therapy [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Brenntag and dsm-firmenich agree global GMP vitamin deal
    Categories: Clinical & Regulatory
  • Laverock Therapeutics expands into in vivo CAR-T and genetic medicine
    Categories: Advanced Therapies, Central Nervous System, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Trixeo approved in EU for asthma
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top